Search
for
Sort by
Research 331–360 of 1000+
- Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database
- The Clinical Efficacy and Mechanism of Action of Alitretinoin in the Treatment of Alopecia Areata
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- 62202 Network meta-analysis (NMA) of FDA-approved JAK inhibitors for alopecia areata (AA) with at least 50% hair loss per SALT score
- Efficacy of Barictinib As Compared to Conventional Therapy as a Treatment for Alopecia Areata
- The Efficacy of Intralesional Pentoxifylline Injection versus the Standard Intralesional Corticosteroid Injection in The Treatment of Alopecia Areata
- Lasers in the management of alopecia: a review of established therapies and advances in treatment
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Topical Bimatoprost (0.03%) Versus Topical Mometasone Furoate (0.1%) in Treatment of Alopecia Areata
- Alopecia areata in children: an overview of clinical features and recent treatment options
- Supplementary Material for: Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- Evaluation of Not-Activated and Activated PRP in Hair Loss Treatment: Role of Growth Factor and Cytokine Concentrations Obtained by Different Collection Systems
- Benefit and risk profile of tofacitinib for the treatment of alopecia areata: a systemic review and meta‐analysis
- Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata
- Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone
- Fabrication of astaxanthin-loaded electrospun nanofiber-based mucoadhesive patches with water‐insoluble backing for the treatment of oral premalignant lesions
- Phototherapy as a Useful Therapeutic Option in the Treatment of Diphenylcyclopropenone-induced Vitiligo
- Th1 Chemokine CXCL10 and Alopecia Areata: The Possible Target for the Treatment of Alopecia Areata
- Clinical Characteristics, Treatment Patterns, and Outcomes of Chinese Patients With Alopecia Areata: A Retrospective Observational Study
- BH21 Efficacy and safety of oral Janus kinase inhibitors in the treatment of alopecia areata: a systematic review and meta-analysis
- Cost‐Effectiveness Analysis of Ritlecitinib Compared With No Treatment in Patients With Severe Alopecia Areata in Japan
- Understanding Eyebrow and Eyelash Involvement in Patients with Alopecia Areata and Responsiveness to Treatment with Baricitinib.
- Markers of inflammation, metabolic disorders, and principles of treatment for alopecia areata in children
- Comparison of Clinical Efficacy and Trichoscopic Changes in Alopecia Areata of the Scalp following Treatment with Intralesional Triamcinolone Acetonide and Autologous Platelet-Rich Plasma
- 026 Targeting pathogenic MICA-NKG2D interactions by statins: A novel adjunct treatment strategy for alopecia areata management?
- Attitudes of dermatologists in the southeastern United States regarding treatment of alopecia areata: a cross-sectional survey study.
- 708 Promotion of hair growth in alopecia areata by topical treatment of HDAC inhibitors
- The methodology of developing dermato-cosmetic remedies for prevention and treatment of alopecia
- 218 Chemokine receptor CCR5 is the novel target for the treatment of alopecia areata
- Topical minoxidil and tretinoin combined with an oral vitamin D analog as a treatment for woolly hair